Ball, B., Gooptu, M., Li, L., Hourigan, C., Mokhtari, S., Yang, D., Farol, L., Samara, Y., Stein, A. S., Marcucci, G., Malki, M. M. A., Cutler, C., Nakamura, R., Aldoss, I. (2025). A multicenter phase 1 trial evaluating the safety and preliminary efficacy of revumenib as post-transplant maintenance after allogeneic hematopoietic cell transplant in patients with KMT2A-rearranged or NPM1-mutated acute leukemia. Blood. https://doi.org/10.1182/blood-2025-5207